MiDatabank is used exclusively in all UKMi centres to log medicines information enquiries. Enquiries are usually from healthcare professionals within the hospital but could be from outside.

Each medicines information enquiry passes through four stages – Input, Research, Answer and Completion. (ADRs have an extra tab). The system will note any data omissions at each stage.

MiDatabank includes as standard:

  • Admin module for system configuration
  • Enquiry module to log and resolve enquiries
  • Auto keywording
  • Research aids with a reference section for electronic and paper resources
  • National Drug Dictionary (DM+D in the UK) to accurately record patient medication
  • FAQ & Project forms
  • Extensive search facilities and helper tools
  • Additional Core Categories
  • User profiles to define level of access and capability
  • Reporting module
  • Letter production with standard paragraphs, text and templates
  • ADR forms with MedDRA dictionary terms

MiDatabank provides a number of extremely useful tools and resources:

  • Provision of a central web-site that contains a master list of resources (books, web-sites, journals) that is regularly kept up-to-date
  • Paper and electronic references - books, journals, papers and Internet subscription services - can all be searched using Standard Search Patterns (SSPs) that match content to the enquiry request.
  • Synchronisation of MiDatabank desktop software between the above master list and the resources list to allow automatic resource updating when new editions of sources are published, or when URLs change etc.
  • Advanced Search facility includes a wide range of limits/filters including enquirer, completed by, complexity status, specialist referral etc.
  • Advanced Report facility includes fields above plus ability to report at all layers of the Origins node structure.
  • Option to report on enquiries completed or in progress.

Reporting ADRs

MiDatabank includes a major feature to enhance patient safety in the Electronic Submissions of ADRs (Yellow Forms) direct to the MHRA.

In the first two years after this feature was implemented, over 1500 ADRs had been sent to the MHRA. Over half were classed as ‘Serious’. This represents a major contribution to patient safety.

For more information see the ADR Resources page.